Spero Therapeutics, Inc. (SPRO)
2.325
+0.02
(+0.65%)
USD |
NASDAQ |
Dec 09, 16:00
2.325
0.00 (0.00%)
After-Hours: 18:50
Spero Therapeutics Profit Margin (Quarterly): -242.2% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Omeros Corp. | -- |
| GeoVax Labs, Inc. | -- |
| Vistagen Therapeutics, Inc. | -7.53K% |
| Daré Bioscience, Inc. | -154.9K% |
| Hyperion DeFi, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.0% |
| Return on Assets | -49.85% |
| Return on Invested Capital | -97.58% |
| Operating Margin (Quarterly) | -319.0% |
| Return on Net Operating Assets | -134.9% |